Discover how the MUC16 protein creates an invisible shield that protects ovarian cancer cells from natural killer cells and macrophages in our immune system.
Groundbreaking research into combinatorial immunotherapy offers new hope for recurrent ovarian cancer patients through personalized multi-pronged immune attacks.